Clinical trial

Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder

Brigham and Women's HospitalNot yet recruitingPhase 2Started Nov 15, 202636 enrolledUnited StatesNCT07296094

Abstract

This study aims to determine the safety and preliminary efficacy of psilocybin-assisted psychotherapy in improving alcohol-related outcomes among adults with severe alcohol use disorder in a a double-blind, dose-comparison concurrent control, randomized trial. Participants will undergo structured psychotherapy and will be randomized to two psilocybin sessions to receive either a full dose (30mg or 40mg) or low dose (10mg or 15mg).

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinAddiction

Keywords

alcohol use disorderinpatient withdrawal managementpsychedelicAlcohol Use Disorder

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

PreprintPsilocybin

Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making

Mitina O, Mirsaidov M, Molchanova N +1

Europe PMC2020

ArticlePsilocybin

Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.

Zhang W, Hwang SY, Luther J

Europe PMC2025

ArticlePsilocybin

Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey.

Glynos NG, Aday JS, Kruger D +3

Europe PMC2024